$17.31+0.23%
2026-10-06 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Summit Therapeutics last closed at $17.31 (+0.23%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -15.7×. Its overall grade ranks 369 of 740 stocks in Healthcare.
About this company
Summit Therapeutics last closed at $17.31 (+0.23%) on 2026-10-06. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 369/740
Valuation grade A
Related stocks
- IvonescimabRelated theme
Summit의 핵심 파이프라인으로, 기업 연결의 중심 축
- AkesoSupplier
ivonescimab 원개발/권리 관련 핵심 파트너로 간주되는 기업
- MerckCompetitor
폐암·면역항암제 시장에서 Summit의 주요 경쟁 축
About Summit Therapeutics
- What technical signals does Summit Therapeutics (SMMT) have?
- Summit Therapeutics current technical signals: no active technical signal.
- Is Summit Therapeutics a cup-and-handle pattern?
- No. Summit Therapeutics has no valid Cup signal right now.
- What published figures are available for Summit Therapeutics?
- Market cap: $12.86B. Trailing 12 months PER: -15.7×. Latest quarter PBR: 21.38×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Summit Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy